About

GADA Canada is dedicated to saving lives and enabling a promising future for individuals living with Marfan syndrome and other genetic aortic disorders through education, awareness, support and research. To succeed in these endeavours GADA is focusing on: 1. Educating and supporting aortic clinics and those with genetic aortic disorders (GADs), 2. Advocating genetic testing for those with GADs to save lives and, 3. Enrolling Canadians with GADs into the MAC patient registry. Montalcino Aortic Consortium (MAC) is an international research collaborative of multidisciplinary clinicians collecting patient data to generate gene- and variant-specific risk models for personalized medicine to improve outcomes of individuals with genetic aortic disease.